Daniel Brennan
Stock Analyst at TD Cowen
(4.95)
# 134
Out of 5,058 analysts
718
Total ratings
59.8%
Success rate
26.4%
Average return
Main Sectors:
Stocks Rated by Daniel Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Reiterated: Buy | $180 → $196 | $175.55 | +11.65% | 42 | Oct 13, 2026 | |
| ADPT Adaptive Biotechnologies | Reiterated: Buy | $28 → $32 | $25.58 | +25.10% | 18 | Oct 13, 2026 | |
| AVTR Avantor | Reiterated: Hold | $15 → $17 | $16.09 | +5.66% | 27 | Oct 13, 2026 | |
| BDSX Biodesix | Reiterated: Buy | $30 → $40 | $24.71 | +61.88% | 11 | Oct 13, 2026 | |
| BRKR Bruker | Reiterated: Hold | $60 → $62 | $56.54 | +9.66% | 27 | Oct 13, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | $30 → $36 | $31.76 | +13.35% | 10 | Oct 13, 2026 | |
| DHR Danaher | Reiterated: Buy | $236 → $255 | $231.50 | +10.15% | 34 | Oct 13, 2026 | |
| GRAL GRAIL | Reiterated: Buy | $88 → $180 | $135.46 | +32.88% | 9 | Oct 13, 2026 | |
| ILMN Illumina | Reiterated: Hold | $210 → $270 | $267.93 | +0.77% | 46 | Oct 13, 2026 | |
| MYGN Myriad Genetics | Reiterated: Hold | $7 → $4.5 | $4.35 | +3.45% | 22 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 → $480 | $404.79 | +18.58% | 28 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $3.5 | $3.07 | +14.01% | 19 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 → $175 | $154.71 | +13.11% | 27 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $675 → $760 | $696.49 | +9.12% | 41 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 → $70 | $72.39 | -3.30% | 34 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $475 → $515 | $444.15 | +15.95% | 30 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $11 | $8.56 | +28.50% | 17 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $12.29 | +38.38% | 1 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $0.6036 | +65.67% | 13 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.03 | - | 16 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.96 | +53.06% | 26 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.29 | - | 15 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 → $210 | $165.88 | +26.60% | 20 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $17.25 | +10.14% | 23 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $34 | $27.42 | +24.00% | 2 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $18 | $15.93 | +12.99% | 16 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $44 | $46.17 | -4.70% | 26 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 → $71 | $71.13 | -0.18% | 20 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $85 | $70.22 | +21.05% | 20 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.16 | - | 12 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.04 | - | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $183 | $193.76 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $0.6584 | n/a | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $525 | $99.09 | n/a | 1 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $44.40 | n/a | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 → $62 | $7.07 | n/a | 3 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $144.49 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | - | n/a | 4 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $390 → $465 | $306.24 | n/a | 7 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $880 → $1,139 | $1,639.04 | n/a | 12 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $224 → $275 | $271.04 | n/a | 4 | Apr 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $174 → $232 | $175.13 | n/a | 8 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $44.39 | n/a | 1 | Nov 26, 2013 |
Agilent Technologies
Oct 13, 2026
Reiterated: Buy
Price Target: $180 → $196
Current: $175.55
Upside: +11.65%
Adaptive Biotechnologies
Oct 13, 2026
Reiterated: Buy
Price Target: $28 → $32
Current: $25.58
Upside: +25.10%
Avantor
Oct 13, 2026
Reiterated: Hold
Price Target: $15 → $17
Current: $16.09
Upside: +5.66%
Biodesix
Oct 13, 2026
Reiterated: Buy
Price Target: $30 → $40
Current: $24.71
Upside: +61.88%
Bruker
Oct 13, 2026
Reiterated: Hold
Price Target: $60 → $62
Current: $56.54
Upside: +9.66%
Caris Life Sciences
Oct 13, 2026
Reiterated: Buy
Price Target: $30 → $36
Current: $31.76
Upside: +13.35%
Danaher
Oct 13, 2026
Reiterated: Buy
Price Target: $236 → $255
Current: $231.50
Upside: +10.15%
GRAIL
Oct 13, 2026
Reiterated: Buy
Price Target: $88 → $180
Current: $135.46
Upside: +32.88%
Illumina
Oct 13, 2026
Reiterated: Hold
Price Target: $210 → $270
Current: $267.93
Upside: +0.77%
Myriad Genetics
Oct 13, 2026
Reiterated: Hold
Price Target: $7 → $4.5
Current: $4.35
Upside: +3.45%
Oct 13, 2026
Reiterated: Buy
Price Target: $340 → $480
Current: $404.79
Upside: +18.58%
Oct 13, 2026
Reiterated: Hold
Price Target: $3 → $3.5
Current: $3.07
Upside: +14.01%
Oct 13, 2026
Reiterated: Buy
Price Target: $130 → $175
Current: $154.71
Upside: +13.11%
Oct 13, 2026
Reiterated: Buy
Price Target: $675 → $760
Current: $696.49
Upside: +9.12%
Oct 13, 2026
Reiterated: Hold
Price Target: $47 → $70
Current: $72.39
Upside: -3.30%
Oct 13, 2026
Reiterated: Buy
Price Target: $475 → $515
Current: $444.15
Upside: +15.95%
Oct 13, 2026
Reiterated: Buy
Price Target: $10 → $11
Current: $8.56
Upside: +28.50%
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $12.29
Upside: +38.38%
Aug 13, 2026
Reiterated: Buy
Price Target: $1
Current: $0.6036
Upside: +65.67%
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.03
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $3
Current: $1.96
Upside: +53.06%
Aug 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.29
Upside: -
Jul 31, 2026
Rated: Buy
Price Target: $200 → $210
Current: $165.88
Upside: +26.60%
Jul 28, 2026
Reiterated: Buy
Price Target: $19
Current: $17.25
Upside: +10.14%
Jul 15, 2026
Reiterated: Buy
Price Target: $30 → $34
Current: $27.42
Upside: +24.00%
Jul 15, 2026
Rated: Buy
Price Target: $10 → $18
Current: $15.93
Upside: +12.99%
Jul 15, 2026
Reiterated: Hold
Price Target: $40 → $44
Current: $46.17
Upside: -4.70%
Jul 15, 2026
Reiterated: Buy
Price Target: $68 → $71
Current: $71.13
Upside: -0.18%
Jul 15, 2026
Reiterated: Buy
Price Target: $55 → $85
Current: $70.22
Upside: +21.05%
Apr 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.16
Upside: -
Feb 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.04
Upside: -
Jul 14, 2025
Reiterated: Hold
Price Target: $183
Current: $193.76
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $2.5
Current: $0.6584
Upside: n/a
Apr 27, 2023
Reiterated: Buy
Price Target: $525
Current: $99.09
Upside: n/a
Apr 26, 2023
Reiterated: Buy
Price Target: $45
Current: $44.40
Upside: n/a
Oct 15, 2021
Reiterated: Buy
Price Target: $68 → $62
Current: $7.07
Upside: n/a
Oct 14, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $144.49
Upside: n/a
Oct 14, 2021
Reiterated: Hold
Price Target: n/a
Current: -
Upside: n/a
Aug 17, 2021
Reiterated: Buy
Price Target: $390 → $465
Current: $306.24
Upside: n/a
May 7, 2021
Reiterated: Sell
Price Target: $880 → $1,139
Current: $1,639.04
Upside: n/a
Apr 23, 2021
Reiterated: Buy
Price Target: $224 → $275
Current: $271.04
Upside: n/a
Mar 1, 2021
Upgraded: Buy
Price Target: $174 → $232
Current: $175.13
Upside: n/a
Nov 26, 2013
Initiated Coverage: Buy
Price Target: $16
Current: $44.39
Upside: n/a